+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sodium Nitroprusside Injection Market - Global Forecast to 2030- Product Image
Sodium Nitroprusside Injection Market - Global Forecast to 2030- Product Image
New

Sodium Nitroprusside Injection Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6085442
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Sodium nitroprusside injection has emerged as a cornerstone therapy for rapid blood pressure control and acute hemodynamic management. As a potent vasodilator, it plays a critical role in treating hypertensive emergencies, acute decompensated heart failure, and as an adjunct in high-risk surgical procedures. Recent advancements in formulation technologies have enhanced its stability profiles, while evolving clinical guidelines continue to broaden its therapeutic applications. With healthcare systems worldwide emphasizing cost efficiency and patient safety, sodium nitroprusside remains under close scrutiny for best-practice administration protocols and supply chain resilience. This report’s executive summary distills the most impactful trends, policy shifts, and competitive dynamics shaping the sodium nitroprusside landscape today. By examining tariff influences, regional variations, segmentation drivers, and leading industry players, we provide an authoritative overview that empowers decision-makers to navigate challenges, identify growth opportunities, and refine strategic priorities in this vital market.

Transformative Shifts in the Sodium Nitroprusside Injection Landscape

Over the past decade, several transformative shifts have redefined the sodium nitroprusside injection landscape. Regulatory authorities worldwide have tightened quality control standards, elevating requirements for purity, preservative levels, and shelf-life validation. Concurrently, pharmaceutical innovators have introduced advanced liquid and powder formulations with optimized concentration ranges, extended shelf stability, and streamlined reconstitution processes-improving both hospital pharmacy workflows and patient safety outcomes. Moreover, the rise of value-based care models has propelled adoption in both acute and chronic cardiovascular programs, while digital health platforms now monitor infusion parameters in real time to mitigate adverse events. Supply chains have also evolved: manufacturers are strategically diversifying active pharmaceutical ingredient sources to enhance resilience, and packaging innovations such as single-use vials have reduced contamination risks. Finally, emerging clinical evidence supporting niche applications in neurocritical care and ventricular assistance has expanded the drug’s utility beyond traditional hypertensive emergencies. Taken together, these developments have recalibrated competitive positioning, encouraging market participants to align product portfolios, distribution strategies, and clinical support services with evolving stakeholder demands.

Cumulative Impact of United States Tariffs on 2025 Supply Chain

In 2025, the introduction of revised United States tariffs has exerted a cumulative impact across the sodium nitroprusside value chain. Manufacturers dependent on imported active pharmaceutical ingredients from select global suppliers have faced elevated input costs, prompting many to reassess sourcing strategies. Hospitals and ambulatory centers are encountering increased procurement expenses, which ripple through budgeting cycles and influence formulary decisions. To counterbalance these pressures, some industry leaders have accelerated domestic production partnerships and leveraged bulk purchase agreements via direct tenders to secure preferential pricing. Retail pharmacies navigating government procurement channels have similarly adapted by strengthening alliances with distributors capable of mitigating tariff pass-through. Consequently, cost efficiency has become a critical differentiator, driving providers to evaluate unit cost against formulation attributes such as concentration flexibility and reconstitution time. Transitioning to local manufacturing or powder formulations has also emerged as a viable mitigation tactic, reducing exposure to import levies. Collectively, these tariff-induced shifts underscore the importance of agile supply chain management and reinforce the competitive advantage of stakeholders who can absorb or offset incremental costs through operational excellence.

Key Segmentation Insights Driving Market Differentiation

Segmentation analysis reveals clear drivers of value and differentiation across product, application, end user, distribution, age group, companion drugs, and packaging categories. Within product type, demand grows most rapidly for liquid formulations with precise concentration titration and extended shelf-life attributes, while powder formats optimized for rapid reconstitution and varied vial sizing appeal to resource-constrained facilities. Application segments underscore sodium nitroprusside’s versatility: it remains indispensable in acute decompensated heart failure and extended ventricular support, complements heart attack and stroke management protocols in hypertensive crises, and facilitates controlled hypotension during cardiothoracic and neurosurgical procedures. Examining end user landscapes, government and private hospitals dominate volume consumption, while advanced ambulatory surgical centers leverage shorter infusion times to optimize throughput; research institutes invest in biotechnological and pharmacological trials to explore novel indications. Distribution channels further stratify value: direct tenders drive bulk hospital procurements, whereas chain and independent pharmacies serve outpatient demand. Age-group considerations highlight adult and middle-aged populations as primary cohorts, yet early geriatric and pediatric dosing studies are expanding safe use parameters. Companion drug pairings with non-selective and selective beta-blockers or loop and thiazide diuretics define co-therapy protocols, and packaging choices between multi-use vials with preservatives versus sterile single-use formats affect adoption in infection-sensitive settings.

Key Regional Insights Shaping Global Market Trends

Regional dynamics are reshaping sodium nitroprusside’s global trajectory in distinct ways. In the Americas, robust cardiovascular care infrastructure and established reimbursement frameworks support early adoption of advanced formulations and packaging innovations, while supply chain optimization initiatives aim to mitigate tariff pressures. Europe, the Middle East & Africa display heterogeneous market maturity: Western Europe emphasizes stringent regulatory compliance and therapeutic guidelines, the Middle East invests in state-of-the-art hospitals driving high-volume usage during surgical procedures, and African markets prioritize cost-effective powder approaches to overcome cold-chain limitations. Across Asia-Pacific, rapid hospital expansion in China and India, combined with growing neurosurgical and cardiac care capabilities, fuels adoption of both liquid and powder formats; local manufacturers are increasingly capturing share through strategic partnerships and price-competitive offerings. These regional contours underscore the imperative for tailored market entry strategies, distribution alliances, and product portfolios aligned with each geography’s regulatory, economic, and clinical environment.

Key Companies Insights and Competitive Dynamics

Competitive dynamics within the sodium nitroprusside injection market are defined by a mix of global pharmaceutical leaders and emerging specialty producers. Baxter International Inc. leverages integrated supply chains and robust hospital procurement networks to maintain broad coverage, while Cipla Limited differentiates through cost-effective powder formulations tailored for price-sensitive segments. Fresenius Kabi AG emphasizes comprehensive clinical support programs, Hospira, Inc. (a Pfizer company) capitalizes on sterile manufacturing expertise, and Lupin Limited and Mylan N.V. (now part of Viatris) compete aggressively on contract manufacturing and generic approvals. Novartis AG and Roche Group focus on leveraging proprietary distribution channels and strategic alliances to secure high-demand hospital tenders, whereas Sanofi S.A. and Teva Pharmaceutical Industries Ltd. target emerging markets with flexible vial sizing and reconstitution efficiencies. Across this landscape, successful players invest in quality assurance, regulatory agility, and value-added services such as infusion device integration to strengthen customer loyalty and drive sustained differentiation.

Actionable Recommendations for Industry Leaders

Industry leaders must adopt a proactive stance to capture growth and fortify market positions. First, optimize supply chain resilience by diversifying ingredient sourcing-establish parallel domestic and international agreements to absorb potential tariff fluctuations. Second, prioritize product portfolio innovation: accelerate development of powder formats with rapid reconstitution and single-use vial options to address infection control and storage constraints. Third, deepen clinical engagement by sponsoring real-world evidence studies in geriatric and pediatric cohorts, and by collaborating with surgical centers to integrate infusion monitoring technologies. Fourth, tailor regional go-to-market models: partner with local distributors in Asia-Pacific, refine tender strategies in the Americas, and align with government health initiatives across Europe, Middle East & Africa. Finally, enhance value proposition through bundled service offerings, combining training programs, digital infusion analytics, and co-therapy protocol guidance, elevating the drug’s position from commodity to clinical solution.

Conclusion: Advancing Strategies for Market Success

The sodium nitroprusside injection market stands at an inflection point defined by rapid innovation, geopolitical complexity, and evolving clinical demands. Stakeholders equipped with nuanced segmentation strategies, resilient supply chains, and dynamic regional approaches will secure competitive advantage. Embracing next-generation formulations and packaging formats enhances patient safety and operational efficiency, while real-world evidence initiatives strengthen clinical credibility. As tariff landscapes shift, agile sourcing and procurement tactics become essential to maintaining cost leadership. Collaboration between pharmaceutical manufacturers, healthcare providers, and regulatory bodies will drive best-practice protocols and facilitate broader adoption in emerging indications. By integrating digital health tools and service packages, companies can transform sodium nitroprusside from a traditional drug commodity into a comprehensive hemodynamic management solution. This strategic convergence of product innovation, market intelligence, and stakeholder alignment will pave the way for sustained growth and improved patient outcomes.

Market Segmentation & Coverage

This research report categorizes the Sodium Nitroprusside Injection Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Liquid Formulation
    • Concentration
    • Shelf Life
  • Powder Formulation
    • Reconstitution Time
    • Vial Size
  • Chronic Heart Failure
    • Acute Decompensated Heart Failure
    • Prolonged Ventricular Assistance
  • Hypertensive Emergencies
    • Heart Attack Management
    • Stroke Management
  • Surgical Procedures
    • Cardiothoracic Surgery
    • Neurosurgery
  • Ambulatory Surgical Centers
    • 24-Hour Centers
    • Office-Based Centers
  • Hospitals
    • Government Hospitals
    • Private Hospitals
  • Research and Academic Institutes
    • Biotechnological Studies
    • Pharmacological Research
  • Direct Tenders
    • Bulk Hospital Purchases
    • Government Procurement
  • Retail Pharmacies
    • Chain Pharmacies
    • Independent Pharmacies
  • Adult
    • Middle-Aged
    • Young Adult
  • Geriatric
    • Advanced Geriatric
    • Early Geriatric
  • Pediatric
    • Children
    • Infants
  • Beta-Blockers
    • Non-Selective Beta-Blockers
    • Selective Beta-Blockers
  • Diuretics
    • Loop Diuretics
    • Thiazide Diuretics
  • Multi-Use Vials
    • With Preservatives
    • Without Preservatives
  • Single-Use Vials
    • Non-Sterile Packaging
    • Sterile Packaging

This research report categorizes the Sodium Nitroprusside Injection Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Sodium Nitroprusside Injection Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Baxter International Inc.
  • Cipla Limited
  • Fresenius Kabi AG
  • Hospira, Inc.
  • Lupin Limited
  • Mylan N.V. (now part of Viatris)
  • Novartis AG
  • Roche Group
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sodium Nitroprusside Injection Market, by Product Type
8.1. Introduction
8.2. Liquid Formulation
8.2.1. Concentration
8.2.2. Shelf Life
8.3. Powder Formulation
8.3.1. Reconstitution Time
8.3.2. Vial Size
9. Sodium Nitroprusside Injection Market, by Application
9.1. Introduction
9.2. Chronic Heart Failure
9.2.1. Acute Decompensated Heart Failure
9.2.2. Prolonged Ventricular Assistance
9.3. Hypertensive Emergencies
9.3.1. Heart Attack Management
9.3.2. Stroke Management
9.4. Surgical Procedures
9.4.1. Cardiothoracic Surgery
9.4.2. Neurosurgery
10. Sodium Nitroprusside Injection Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. 24-Hour Centers
10.2.2. Office-Based Centers
10.3. Hospitals
10.3.1. Government Hospitals
10.3.2. Private Hospitals
10.4. Research and Academic Institutes
10.4.1. Biotechnological Studies
10.4.2. Pharmacological Research
11. Sodium Nitroprusside Injection Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tenders
11.2.1. Bulk Hospital Purchases
11.2.2. Government Procurement
11.3. Retail Pharmacies
11.3.1. Chain Pharmacies
11.3.2. Independent Pharmacies
12. Sodium Nitroprusside Injection Market, by Age Group
12.1. Introduction
12.2. Adult
12.2.1. Middle-Aged
12.2.2. Young Adult
12.3. Geriatric
12.3.1. Advanced Geriatric
12.3.2. Early Geriatric
12.4. Pediatric
12.4.1. Children
12.4.2. Infants
13. Sodium Nitroprusside Injection Market, by Companion Drugs
13.1. Introduction
13.2. Beta-Blockers
13.2.1. Non-Selective Beta-Blockers
13.2.2. Selective Beta-Blockers
13.3. Diuretics
13.3.1. Loop Diuretics
13.3.2. Thiazide Diuretics
14. Sodium Nitroprusside Injection Market, by Form of Packaging
14.1. Introduction
14.2. Multi-Use Vials
14.2.1. With Preservatives
14.2.2. Without Preservatives
14.3. Single-Use Vials
14.3.1. Non-Sterile Packaging
14.3.2. Sterile Packaging
15. Americas Sodium Nitroprusside Injection Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Sodium Nitroprusside Injection Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Sodium Nitroprusside Injection Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Baxter International Inc.
18.3.2. Cipla Limited
18.3.3. Fresenius Kabi AG
18.3.4. Hospira, Inc.
18.3.5. Lupin Limited
18.3.6. Mylan N.V. (now part of Viatris)
18.3.7. Novartis AG
18.3.8. Roche Group
18.3.9. Sanofi S.A.
18.3.10. Teva Pharmaceutical Industries Ltd
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix

List of Figures
FIGURE 1. SODIUM NITROPRUSSIDE INJECTION MARKET MULTI-CURRENCY
FIGURE 2. SODIUM NITROPRUSSIDE INJECTION MARKET MULTI-LANGUAGE
FIGURE 3. SODIUM NITROPRUSSIDE INJECTION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SODIUM NITROPRUSSIDE INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SODIUM NITROPRUSSIDE INJECTION MARKET, FPNV POSITIONING MATRIX, 2024


List of Tables
TABLE 1. SODIUM NITROPRUSSIDE INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CONCENTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SHELF LIFE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RECONSTITUTION TIME, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY VIAL SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ACUTE DECOMPENSATED HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PROLONGED VENTRICULAR ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HEART ATTACK MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY STROKE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY 24-HOUR CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY OFFICE-BASED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PHARMACOLOGICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BULK HOSPITAL PURCHASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GOVERNMENT PROCUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MIDDLE-AGED, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY YOUNG ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADVANCED GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY EARLY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY NON-SELECTIVE BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SELECTIVE BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LOOP DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY THIAZIDE DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY WITH PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY WITHOUT PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY NON-STERILE PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY STERILE PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 154. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 159. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 160. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 161. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 163. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 165. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 167. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 168. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 169. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 170. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 171. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 172. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 173. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 174. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 175. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 176. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 177. CANADA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 180. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 181. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 183. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 184. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 185. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 187. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 188. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 189. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 191. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 192. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 193. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 194. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 195. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 196. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 197. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 198. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 199. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 200. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 201. MEXICO SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 276. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 278. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY POWDER FORMULATION, 2018-2030 (USD MILLION)
TABLE 279. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 281. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCIES, 2018-2030 (USD MILLION)
TABLE 282. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 283. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 285. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 287. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIRECT TENDERS, 2018-2030 (USD MILLION)
TABLE 289. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 290. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 291. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 292. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 293. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 294. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY COMPANION DRUGS, 2018-2030 (USD MILLION)
TABLE 295. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY BETA-BLOCKERS, 2018-2030 (USD MILLION)
TABLE 296. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY DIURETICS, 2018-2030 (USD MILLION)
TABLE 297. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY FORM OF PACKAGING, 2018-2030 (USD MILLION)
TABLE 298. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY MULTI-USE VIALS, 2018-2030 (USD MILLION)
TABLE 299. CHINA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY SINGLE-USE VIALS, 2018-2030 (USD MILLION)
TABLE 300. INDIA SODIUM NITROPRUSSIDE INJECTION MARKET SIZE, BY PR

Companies Mentioned

  • Baxter International Inc.
  • Cipla Limited
  • Fresenius Kabi AG
  • Hospira, Inc.
  • Lupin Limited
  • Mylan N.V. (now part of Viatris)
  • Novartis AG
  • Roche Group
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd

Methodology

Loading
LOADING...

Related Topics

Related Reports

Sodium Nitroprusside (CAS 13755-38-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Sodium Nitroprusside (CAS 13755-38-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Nitroprusside Sodium (CAS 14402-89-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Nitroprusside Sodium (CAS 14402-89-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Potassium Nitroprusside (CAS 14709-57-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Potassium Nitroprusside (CAS 14709-57-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Ropivacaine Hydrochloride & Sodium Chloride Injection Market - Global Forecast to 2030 - Product Image

Ropivacaine Hydrochloride & Sodium Chloride Injection Market - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global, United States Global, United States
From
Sodium Hyaluronate Intra-Articular Injection Market - Global Forecast to 2030 - Product Image

Sodium Hyaluronate Intra-Articular Injection Market - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global, United States Global, United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.